GR3023308T3 - Inhibitor for restenosis after percutaneous coronary arterioplasty. - Google Patents

Inhibitor for restenosis after percutaneous coronary arterioplasty.

Info

Publication number
GR3023308T3
GR3023308T3 GR970400964T GR970400964T GR3023308T3 GR 3023308 T3 GR3023308 T3 GR 3023308T3 GR 970400964 T GR970400964 T GR 970400964T GR 970400964 T GR970400964 T GR 970400964T GR 3023308 T3 GR3023308 T3 GR 3023308T3
Authority
GR
Greece
Prior art keywords
restenosis
percutaneous coronary
inhibitor
substituted
alkyl
Prior art date
Application number
GR970400964T
Other languages
English (en)
Inventor
Kazuhisa Kodama
Atsushi Hirayama
Hiroyuki Masayasu
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of GR3023308T3 publication Critical patent/GR3023308T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GR970400964T 1992-01-17 1997-05-02 Inhibitor for restenosis after percutaneous coronary arterioplasty. GR3023308T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP655292 1992-01-17
PCT/JP1993/000045 WO1993013762A1 (en) 1992-01-17 1993-01-14 Inhibitor for restenosis after percutaneous coronary arterioplasty

Publications (1)

Publication Number Publication Date
GR3023308T3 true GR3023308T3 (en) 1997-08-29

Family

ID=11641498

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970400964T GR3023308T3 (en) 1992-01-17 1997-05-02 Inhibitor for restenosis after percutaneous coronary arterioplasty.

Country Status (11)

Country Link
US (1) US5480888A (el)
EP (1) EP0622076B1 (el)
JP (1) JPH05255084A (el)
KR (1) KR100214453B1 (el)
AT (1) ATE150964T1 (el)
CA (1) CA2126465C (el)
DE (1) DE69309435T2 (el)
DK (1) DK0622076T3 (el)
ES (1) ES2100520T3 (el)
GR (1) GR3023308T3 (el)
WO (1) WO1993013762A1 (el)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6395494B1 (en) 1993-05-13 2002-05-28 Neorx Corporation Method to determine TGF-β
US5770609A (en) 1993-01-28 1998-06-23 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US5847007A (en) 1993-05-13 1998-12-08 Neorx Corporation Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
US6306421B1 (en) 1992-09-25 2001-10-23 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6251920B1 (en) 1993-05-13 2001-06-26 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6663881B2 (en) 1993-01-28 2003-12-16 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5824644A (en) * 1994-07-07 1998-10-20 G. D. Searle & Co. Method of attenuating arterial stenosis
US20030083733A1 (en) * 1997-10-10 2003-05-01 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6099562A (en) * 1996-06-13 2000-08-08 Schneider (Usa) Inc. Drug coating with topcoat
US5837313A (en) * 1995-04-19 1998-11-17 Schneider (Usa) Inc Drug release stent coating process
US20020091433A1 (en) * 1995-04-19 2002-07-11 Ni Ding Drug release coated stent
WO1996033712A1 (fr) * 1995-04-25 1996-10-31 Daiichi Pharmaceutical Co., Ltd. Remede pour lutter contre le syndrome de l'immunodeficience acquise
AU6277396A (en) * 1995-06-07 1996-12-30 Neorx Corporation Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
TW565558B (en) * 1995-11-09 2003-12-11 Chugai Pharmaceutical Co Ltd Intimal thickening inhibitory agent
AU6959898A (en) * 1997-04-11 1998-11-11 David J. Grainger Compounds and therapies for the prevention of vascular and non-vascular pathol ogies
AU3457300A (en) 1999-03-31 2000-10-16 Daiichi Pharmaceutical Co., Ltd. Substrates for thioredoxin reductase
US6613083B2 (en) * 2001-05-02 2003-09-02 Eckhard Alt Stent device and method
US7776925B2 (en) * 2002-03-06 2010-08-17 Duke University Reversing, postponing or preventing the occurrence of GTN tolerance and/or generation of reactive oxygen species from mitochondria
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3407511A1 (de) * 1984-03-01 1985-09-05 A. Nattermann & Cie GmbH, 5000 Köln Benzisoselenazolthione, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3422962A1 (de) * 1984-06-22 1986-01-02 A. Nattermann & Cie GmbH, 5000 Köln Glutathion-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
EP0165534B1 (de) * 1984-06-22 1989-03-15 A. Nattermann & Cie. GmbH S-(Carbamoyl-phenylselenyl)-Derivate des Glutathions und von Aminomercaptocarbonsäuren, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
DE3443467A1 (de) * 1984-11-29 1986-05-28 A. Nattermann & Cie GmbH, 5000 Köln Mercaptanderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3663139D1 (en) * 1985-04-12 1989-06-08 Nattermann A & Cie Diseleno-bis-benzamides of primary and secondary amines, processes for their production and pharmaceutical preparations containing them
DE3626554A1 (de) * 1986-08-06 1988-02-18 Nattermann A & Cie Diselenobis-benzoesaeureamide primaerer heterocyclischer amine, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische praeparate
JP2710633B2 (ja) * 1987-08-28 1998-02-10 第一製薬株式会社 心臓疾患治療剤
JP2596970B2 (ja) * 1988-05-23 1997-04-02 第一製薬株式会社 白血球の粘着又は凝集抑制剤
US5187105A (en) * 1988-07-01 1993-02-16 Miles Inc. Process for determining thiols using chromogenic benzoisothiazolone derivatives
DE3937169A1 (de) * 1989-11-08 1991-05-16 Nattermann A & Cie Benzylselenobenzamide von anilinen und benzylaminen

Also Published As

Publication number Publication date
CA2126465C (en) 2002-03-05
ATE150964T1 (de) 1997-04-15
DE69309435T2 (de) 1997-07-10
DK0622076T3 (da) 1997-06-02
ES2100520T3 (es) 1997-06-16
KR100214453B1 (ko) 1999-08-02
EP0622076B1 (en) 1997-04-02
EP0622076A4 (en) 1994-12-21
US5480888A (en) 1996-01-02
EP0622076A1 (en) 1994-11-02
JPH05255084A (ja) 1993-10-05
DE69309435D1 (de) 1997-05-07
WO1993013762A1 (en) 1993-07-22
CA2126465A1 (en) 1993-07-22

Similar Documents

Publication Publication Date Title
GR3023308T3 (en) Inhibitor for restenosis after percutaneous coronary arterioplasty.
LU91210I2 (fr) Emodepside & Praziquantel ainsi que leurs dérivés pharmaceutiqement acceptables (PROFENDER)
FI953968A (fi) Antraniiliset happojohdannaiset
IL113313A (en) Heterocyclic compounds and pharmaceutical compositions containing the same
DE69935718D1 (de) Antidiabetische medikamente
DE69215694D1 (de) Benzamid-derivate
AU755654C (en) Novel amide compounds and drugs containing the same
ATE182331T1 (de) Oxazolidone derivative als monoamine- oxidaseinhibitoren
NZ221699A (en) Pyridazinone derivatives; pharmaceutical compositions and intermediates
ATE240949T1 (de) Epoxysuccinamid-derivate oder ihre salze
EP1219607A4 (en) INTEGRASE INHIBITORS WITH AN AROMATIC HETEROCYCLUS
EP1375489A4 (en) MEDICINAL PREPARATION CONTAINING A 1,3-THIAZINE DERIVATIVE
ATE205209T1 (de) Chinolincarbonsäurederivate und ihre salze
DE69620175D1 (de) Hydroxylamin-derivate mit anti-ischämischer wirkung und pharmazeutische zusammensetzungen diese enthaltend
HU9600597D0 (en) 4-alkylthio-pyrimidin-5-yl acetic acid derivates and fungicidal compositions containing them as an active ingredient
DE69314929D1 (de) Benzolderivate